CRMevidence™

02 / Our capabilities

Regulatory & Institutional Access

Regulatory approval, institutional access and commercial procurement are related but distinct pathways. Requirements differ by product category, intended use and route to market.

A specialist reviews a dossier beside a diagnostic device.
AI-assisted illustration of a fictional dossier review.

Regulatory and institutional access roadmap

An example of how to plan access for a medical device in Mexico.

  1. Define the product

    Document the intended use, product characteristics and planned distribution model.

    Potential outputBasis for classification and review of the registration pathway

  2. Review the regulatory pathway

    Identify requirements and potential procedures for the product category.

    Potential outputOverview of requirements and open questions

  3. Prepare the dossier

    Review technical, clinical and administrative documentation and identify gaps.

    Potential outputDossier checklist with responsibilities

  4. Plan institutional access

    Review purchasing channels and additional requirements at target institutions.

    Potential outputPlan for the next steps with target institutions

The challenge

Regulatory approval, institutional access and commercial procurement are related but distinct pathways. Requirements differ by product category, intended use and route to market.

How CRMevidence could support

Map applicable regulatory and documentation workstreams, including relevant COFEPRIS processes; identify institutional stakeholders and purchasing pathways; coordinate questions for authorised regulatory specialists; assess evidence and product-information readiness.

Potential project outputs

A regulatory and institutional stakeholder map, documentation gap list, responsibility matrix and phased action plan for local market access.

Important qualification

No approval, registration or inclusion in an institutional catalogue is guaranteed. Product-specific legal and regulatory conclusions must be confirmed by authorised professionals.

Additional detail from CRMevidence corporate profile (November 2026)

The CRMevidence corporate profile describes medical-device classification, COFEPRIS registration strategy, dossier preparation, establishment compliance, distribution controls and post-market obligations. It distinguishes regulatory authorisation from institutional inclusion and purchasing decisions.

Proposed service scope. Subject to confirmation by CRMevidence.